Picture of Cellebrite DI logo

CLBT — Cellebrite DI News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousMid CapHigh Flyer

Digital investigative solutions firm Cellebrite's Q3 revenue beats estimates

Overview

Cellebrite Q3 revenue grows 18% yr/yr, beating analyst expectations

Adjusted EBITDA for Q3 beats estimates, reflecting strong operational performance

Net income for Q3 misses analyst expectations

Outlook

Cellebrite expects full-year 2025 revenue of $470 mln to $475 mln

Company forecasts 2025 ARR of $460 mln to $475 mln

Cellebrite anticipates Q4 2025 adjusted EBITDA of $35 mln to $38 mln

Result Drivers

U.S. FEDERAL BUSINESS - Significant expansion with marquee clients in U.S. Federal sector contributed to growth

SUBSCRIPTION REVENUE - 21% growth in subscription revenue driven by demand in U.S. state and local and Latin America segments

PRODUCT INNOVATION - Autumn 2025 Release with new capabilities and integrations enhanced digital investigation solutions

Key Details

MetricBeat/MissActualConsensus Estimate
Q3 RevenueBeat$126.03 mln$122.01 mln (8 Analysts)
Q3 Adjusted EPS$0.14
Q3 Net IncomeMiss$20.19 mln$31.53 mln (4 Analysts)
Q3 Adjusted EBITDABeat$37.74 mln$32.18 mln (7 Analysts)
Q3 Gross Margin83.90%
Q3 Cash Flow from Operating Activities$33.27 mln
Q3 Operating Income$18.99 mln
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", no "hold" and no "sell" or "strong sell" The average consensus recommendation for the software peer group is "buy" Wall Street's median 12-month price target for Cellebrite DI Ltd is $23.00, about 31.7% above its November 11 closing price of $15.70 The stock recently traded at 30 times the next 12-month earnings vs. a P/E of 29 three months ago Press Release: ID:nGNX3QwFRl For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Cellebrite DI

See all news